Filgotinib

Status:
Do Not Prescribe (DNP)
Decision Date:
January 2021
 

Comments

Treatment of moderate to severe active rheumatoid arthritis in adults who have responded inadequately to, or who are intolerant to one or more disease modifying anti-rheumatic drugs, as monotherapy or in combination with methotrexate

search again

Derby and Derbyshire CCG

Derby and Derbyshire CCG